Risk factors for atrophic chronic gastritis in a European population: Results of the Eurohepygast study

Gut

Volumn 50, Issue 6, 2002, Pages 779-785

  Broutet, Nathalie ^a,b   Mégraud, Francis ^b   O'Morain, Colm ^b   Sipponen, Pentti ^b   Price, Ashley ^b   Malfertheiner, Peter ^b   Moran, Anthony ^b   Munoz, Nubia ^b   Dabis, François ^b   Figura, N ^b   Hynes, S ^b   Plebani, M ^b   Wadstrom T ^b   Sakarovitch, C ^b   Nachit, F ^b   Arenas, I M ^b   Blasi, A ^b   Bretagne, J F ^b   Chaussade, S ^b   Delchier, J C ^b   DeKorwin, J D ^b   Duda, D ^b   Dzieniszewski, J ^b   Fixa, B ^b   Gisbert, J ^b   Goldis, A ^b   Guerre, J ^b   Hryniewiecki, L ^b   Inserra, G ^b   Karvonen, A L ^b   Knapik, Z ^b   Kolke, H ^b   Lamouliatte, H ^b   Le Coustumier, A ^b   Linke, K ^b   Lonovics, J ^b   Maaroos, H ^b   Michopoulos, S ^b   Mones J ^b   Pajares J G ^b   Paradowski, L ^b   Peitz, U ^b   Pinto, S ^b   Quina, M ^b   Trautmann, G ^b   Tchernev, K ^b   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GENE PRODUCT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL VIRULENCE; BEHAVIOR; CORRELATION ANALYSIS; DIET; EUROPE; FAMILY HISTORY; FEMALE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SOCIOECONOMICS;

EID: 0036112351     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.6.779     Document Type: Article

References (67)

1. Studies of patients with atrophic gastritis: A 10-15-year follow-up
2. The recognition of atrophic gastritis
3. Carcinoma and intestinal metaplasia of the gastric mucosa in Colombian migrants
4. A reappraisal of the nature and significance of chronic atrophic gastritis
5. The epidemiology and pathogenesis of chronic gastritis: Three etiologic entites
6. Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data
7. The incidence of Helicobacter pylori infection
8. Epidemiology of H. pylori infection
9. Intrastrain differences in Helicobacter pylori: A key question in mucosal damage?
10. Diet and chronic atrophic gastritis: A case-control study
11. Determinants of Helicobacter pylori infection and chronic gastritis
12. The Sydney system: Endoscopic division. Endoscopic appearances in gastritis/duodenitis
13. Classification and grading of gastritis: The updated Sydney system
14. The Sydney system: Histological division
15. Antimicrobial susceptibilily testing of Helicobacter pylori in a large multicenter trial: The MACH 2 study
16. Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection af serum immunoglobulin G (IgG) and IgA antibodies
17. Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains
18. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in the bile: Is it a risk factor for gallstone formation?
19. Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy
20. Symptomatic volunteers in multicenter drug trials
21. Outpatient treatment of neurotic depression: Medication and group psychotherapy
22. Issues relating to normalization of body fat content in men and women
23. Ecological analysis of the association between mortalily and maior risk factors of cardiovascular disease
24. Model-building strategies
25. Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men
26. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle
27. Helicobacter pylori infection and atrophic gastritis - A nested case-control study in a rural town in Japan
28. Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan
29. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
30. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis
31. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy
32. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
33. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico
34. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori - Association of specific vacA types with cytotoxin production and peptic ulceration
35. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
36. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: Comparison of histology, C-13-urea breath test, and serology
37. Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time
38. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma
39. Family history and risk of stomach cancer in Warsaw, Poland
40. Family history-related risk of gastric cancer in Japan: A hospital-based case-control study
41. Family history and risk of stomach cancer in Italy
42. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
43. Familial predisposition to precancerous gastric lesions in a high-risk area of China
44. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
45. Genetic etiology of gastric carcinoma: Chronic atrophic gastritis
46. Enrichment of combined antral and corpus atrophic gastritis ("combined AG") in sibs of gastric carcinoma patients
47. Helicobacter pylori among preschool children and their parents: Evidence of parent-child transmission
48. Protective factor against progression from atrophic gastritis to gastric cancer - Data from a cohort study in Japan
49. Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region
50. Mortality in relation to smoking: 40 Years' observations on male British doctors
51. Tobacco smoking and gastric cancer: Review and meta-analysis
52. Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland
53. The beneficial effect af corticosteroids in a patient with simple atrophic gastritis. A case report
54. Description selon le DSM III et diagnostic "intuitif" de 1298 déprimés suivis en ambulatoire par des psychiatres français
55. Dimensions of outpatient neurotic pathology: Comparison of a clinical versus an empirical assessment
56. Helicobacter pylori gastritis in Africa
57. Long-term course and consequences of Helicobacter pylori gastritis - Results of a 32-year follow-up study
58. Review article: Pathogenesis of the transformation from gastritis to malignancy
59. Gastric precancerous process in a high risk population: Cohort follow-up
60. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: A follow up study
61. Fhit expression in gastric adenocarcinoma - Correlation with disease stage and survival
62. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives
63. HLA-DQB1 locus and the development of atrophic gastritis with Helicobacter pylori infection
64. Loss of FHIT expression in gastric carcinoma
65. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients: An age and gender matched case-control study
66. Helicobacter pylori and gastric carcinoma